This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Cancer Center. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations in Cancer Diagnosis and Treatment by Sung-Hye Hong
Introduction
Sung-Hye Hong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer. His innovative work has led to the development of a unique cancer marker-detecting composition.
Latest Patents
Sung-Hye Hong holds 1 patent for his invention titled "Use of eIF3m for the diagnosis and treatment of cancer." This patent discloses a cancer marker-detecting composition that includes an agent for measuring the mRNA or protein expression level of eIF3m. It also encompasses a cancer diagnosis kit and methods for detecting eIF3m polynucleotides or proteins in biological specimens. Furthermore, the invention outlines a method for the treatment and prevention of cancer by down-regulating the expression of eIF3m.
Career Highlights
Sung-Hye Hong is affiliated with the National Cancer Center, where he continues to advance cancer research and treatment methodologies. His work is pivotal in enhancing the understanding of cancer markers and improving diagnostic techniques.
Collaborations
He collaborates with notable colleagues, including Sung-Ho Goh and Yeon-Su Lee, to further his research initiatives and contribute to the scientific community.
Conclusion
Sung-Hye Hong's innovative contributions to cancer diagnosis and treatment exemplify the impact of research and invention in the medical field. His work continues to inspire advancements in cancer care and research methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile